Omega-3 Dosage: EPA vs DHA and How Much You Actually Need
EPA and DHA have different effects. This guide explains which omega-3 fractions matter for inflammation, cardiovascular health, and brain function — and how to read your supplement label.
Quick Answer
EPA and DHA are the two omega 3 fatty acids with the most clinical evidence. EPA is more relevant for inflammation and mood; DHA is more relevant for brain structure and eye health.
Key Takeaways
- 01---
- 02**How to calculate your actual dose:**
- 03Find the EPA and DHA amounts listed separately on the Supplement Facts panel.
- 04Add them together.
- 05Multiply by your daily serving size.
Quick Answer
EPA and DHA are the two omega-3 fatty acids with the most clinical evidence. EPA is more relevant for inflammation and mood; DHA is more relevant for brain structure and eye health. Most people benefit from 1–3 g combined EPA+DHA/day. The dose on your label likely refers to total fish oil weight, not EPA+DHA — check the nutrition panel.
Why Label Reading Matters Here
A typical 1,000 mg fish oil capsule may contain only 300 mg EPA+DHA combined. The rest is other fats. When studies cite "3 g/day omega-3," they mean 3 g EPA+DHA — not 3 g fish oil. This is one of the most common sources of underdosing in supplementation.
How to calculate your actual dose:
- Find the EPA and DHA amounts listed separately on the Supplement Facts panel.
- Add them together.
- Multiply by your daily serving size.
EPA vs DHA: Different Roles
| EPA | DHA | |
|---|---|---|
| Primary role | Anti-inflammatory signalling | Brain and retinal structure |
| Mood/depression evidence | Stronger | Weaker |
| Cardiovascular evidence | Stronger (especially high dose) | Moderate |
| Brain development (infants) | Supporting role | Essential |
Some conditions benefit more from a high EPA ratio (depression, inflammation); others from DHA (neurodevelopment, cognitive ageing). Most general-use supplements use a roughly 60:40 EPA:DHA ratio.
Cardiovascular Evidence
The REDUCE-IT trial (2018, n=8,179) showed 4 g/day of prescription-grade pure EPA (icosapentaenoic acid / Vascepa) reduced major cardiovascular events by 25% in high-risk patients. This is a landmark result — but note it used a very high dose of pure EPA in a specific patient population, not a general supplement.
Lower doses (1 g EPA+DHA/day) show consistent but modest cardiovascular benefits in meta-analyses. The effect size is smaller at typical supplement doses.
Brain and Mood Evidence
A 2019 meta-analysis of 26 RCTs found omega-3 supplementation significantly reduced depressive symptoms, with EPA-predominant formulas showing larger effects than DHA-predominant ones. The effect size was clinically meaningful but modest.
Omega-3s are not a replacement for antidepressant therapy, but 1–2 g EPA/day as an adjunct is supported by moderate evidence in clinical practice guidelines in some countries.
Dosage Reference
| Goal | Suggested EPA+DHA |
|---|---|
| General health maintenance | 500–1,000 mg/day |
| Cardiovascular risk reduction | 1,000–2,000 mg/day |
| Depression (adjunct) | 1,000–2,000 mg EPA-dominant/day |
| Triglyceride reduction | 3,000–4,000 mg/day (often prescription) |
Forms: Fish Oil, Krill Oil, Algae Oil
- Fish oil: Most data, cheapest per gram of EPA+DHA. Look for triglyceride (TG) form over ethyl ester (EE) for better absorption.
- Krill oil: Higher bioavailability claimed but smaller absolute amounts of EPA+DHA per capsule. More expensive.
- Algae oil: Vegan source of DHA and EPA. EPA content varies by brand but is improving.
Safety Notes
- Blood thinning: Omega-3s have mild antiplatelet effects. At doses above 3 g/day, discuss with a doctor if you are on anticoagulants.
- Fish burps: Take capsules with a meal. Enteric-coated capsules reduce this reliably.
- Oxidation: Rancid fish oil may negate benefits. Check for a certificate of analysis or third-party freshness certification (IFOS, MARIN Trust).
FAQ
Frequently Asked Questions
Medically reviewed
Last reviewed May 9, 2026 by Migaku Editorial Team